Treatment of ischemic heart disease Flashcards

1
Q

What is ischemic heart disease?

A

A consequence of inadequate coronary perfusion relative to
myocardial demand.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the causes of myocardial ischemia

A

Pre-existing (“fixed”) atherosclerotic occlusion of the coronary
arteries
* Acute plaque change with superimposed thrombosis and/or
vasospasm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is angina pectoris

A

Characteristic chest pain (burning or heavy discomfort behind the sternum), of duration <
15 minutes, due to myocardial ischaemia, usually occurring on exercise and relieved by
rest

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

3 steps in the tx of angina pectoris

A
  1. B-Blocker: Atenolol
  2. Add 2nd agent: Long acting calcium channel blocker: Amlodipine
  3. Add 3rd agent: Isosorbide mononitrate/dinitrate
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the Long-term prophylaxis for thrombosis/cardiovascular events?

A

Aspirin, oral, 150 mg daily.
HMGCoAreductase inhibitor (statin)
Simvastatin / Rosuvastatin
Atorvastatin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Tx for relief of angina

A

Nitrates, short acting e.g.:
Isosorbide dinitrate, sublingual, 5 mg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Pt counselling points regarding Tx for angina relief (4)

A

o Maybe repeated if required at 5‐minute intervals for 3 or 4 doses.
o Instruct patients to keep the tablets in the airtight and lightproof container in
which they are supplied.
o Instruct patients that nitrates are not addictive.
o Instruct patients to use prophylactically, before activities which may provoke
angina.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

List 3 organic nitrates

A
  • Glyceryl trinitrate
  • Isosorbide mononitrate
  • Isosorbide dinitrate
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the actions of nitrates?

A

Relax smooth muscle, especially vascular smooth muscle (also
oesophageal and biliary)
* Relax veins, reduction in central venous pressure (reduced preload)
* Reduced stroke volume = venous pooling on standing, postural hypotension and dizziness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

T/F: Therapeutic doses have less effect on
small resistance arteries than on veins
but marked effect on larger muscular
arteries.

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Effects of organic nitrates on coronary arteries

A

Direct dilation of coronary
arteries – increased coronary flow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

effects of organic nitrates on myocardial oxygen consumption

A

Decreased myocardial oxygen consumption (decreased pre- & afterload)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Effects of organic nitrates on coronary sinus blood

A

Increased oxygenation of coronary sinus blood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Effects of organic nitrates on collateral vessels

A

dilation of collateral vessels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

State 3 anti-anginal actions of organic nitrates

A
  • Reduced cardiac work – reduced pre- & after load = reduced oxygen
    demand
  • Redistribution of coronary flow to ischaemic areas via collaterals
  • Relief of coronary spasm
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Adverse effects of nitrates

A

Main adverse effects are direct consequence of pharmacological action
(type A)
* Postural hypotension and headache – tolerance to these effects
develops quickly

17
Q

T/F: Glyceryl nitrate is rapidly inactivated by hepatic metabolism

A

T

18
Q

ROA and onset of action of glyceryl trinitrate

A

sublingual – onset of action = few minutes
converted to di- and mononitrates

Can also be absorbed through the skin – transdermal patch

19
Q

Duration of action of glyceryl trinitrate

A

30min

20
Q

Organic nitrates are highly ____________________
so they evaporate quickly when opened.

A

Volatile

21
Q

Which formulation of organic nitrates is more stable?

A

Spray

22
Q

Isosorbide mononitrate pharmacokinetics, ROA and dosage instructions

A

Isosorbide mononitrate: longer acting, absorbed and metabolised
more slowly.
* Route of administration: oral
* Take twice daily in the morning (8:00) and at lunch (14:00) to allow
for the nitrate free period (to avoid tolerance)

23
Q

Least lipophilic cardio-selective b-blocker

A

Atenolol - loses selectivity at high doses

24
Q

Excretion and frequency of dose of atenolol

A

Excreted mainly unchanged in the urine – may accumulate in kidney
failure

give once daily

25
Q

T/F: Atenolol is affected by liver disease, or drugs inhibiting hepatic metabolism
or conditions affecting hepatic blood flow

A

F. It is not affected

26
Q

contraindications of atenolol (4)

A

Contraindicated in heart block, symptomatic heart failure (unless or
until signs are controlled), sinus bradycardia, cardiogenic shock

27
Q

Cautions of atenolol 2

A

renal failure, pregnancy

28
Q

Drug interactions with atenolol

A

Digoxin, verapamil, diltiazem additive depressant effects on the heart;
* Insulin/oral antidiabetics, increased risk of hyperglycaemia and masking of hypoglycaemia (except sweating)

29
Q

adverse effects of atenolol

A

Decreased HDL, increased TGs and glucose utilization impairment, bronchospasm (asthma, high doses)

30
Q

4 characteristics of unstable angina

A

angina at rest or minimal effort
* angina occurring for the first time, particularly if it occurs at rest
* prolonged angina > 10 minutes, not relieved by sublingual nitrates
* the pattern of angina accelerates and gets worse

31
Q

5 short term Tx goals for acute coronary syndrome

A

Early restoration of blood flow to the infarct-related artery to prevent
infarct expansion (in the case of MI) or prevent complete occlusion and MI (in UA);
* Prevention of death and other MI complications;
* Prevention of coronary artery re-occlusion
* Relief of ischemic chest discomfort.

32
Q

3 long term Tx goals for acute coronary syndrome

A

Control of atherosclerosis risk factors,
* Prevention of additional MACE, including reinfarction, stroke, and HF
* Improvement in quality of life.

33
Q
A